News
First Subject Enrolled in Phase II/III Study of Eisai’s Anti-MTBR Tau Antibody E2814 for Dominantly Inherited Alzheimer’s Disease (DIAD), conducted by DIAN-TU
Eisai Co., Ltd. - Jan 19 2022
New Alzheimer’s prevention trial in young people
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE NEWS RELEASE - DEC 20 2021
$11.5 million commitment supports new Alzheimer’s prevention clinical trial
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE NEWS RELEASE - DEC 20 2021
International Alzheimer’s clinical trial to test two drugs in combination
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE NEWS RELEASE - NOV 8 2021
Global Incubator Seed Grants awarded
The Source, Washington University in St. Louis - Sept 23, 2021
The Search for a Drug to End Alzheimer’s
Some antiamyloids remove target plaques from the brain, yet don't seem to halt cognitive decline. Researchers are working to understand...
IEEE PulseAiming at the Tangle’s Heart? DIAN-TU Trial to Torpedo Tau’s Core
ALZFORUM - MAR 18, 2021Encouraging findings in Alzheimer’s prevention trial lead to the next phase
Neuroscience Research Australia (NeuRA) website - MAR 15, 2021
International Alzheimer’s clinical trial to test tau drugs
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE NEWS RELEASE - MAR 15 2021
Bateman, Diamond, Hultgren named to National Academy of Inventors
School of Medicine scientists honored for innovation
The Source, Washington University in St. Louis - December 8, 2020